Literature DB >> 28414239

A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.

Lihua Huang1, Ning Wang1, Charles E Mitchell1, Tammy Brownlee1, Steven R Maple1, Michael R De Felippis1.   

Abstract

Residual host cell proteins (HCPs) in biopharmaceuticals derived from recombinant DNA technology can present potential safety risks to patients or compromise product stability. Thus, the downstream purification process is designed to demonstrate robust removal of these impurities. ELISA using polyclonal anti-HCP antibodies as reagents for capture, detection, and quantitation purposes is most commonly used to monitor HCP removal during process development, but this technique has limitations. More recently, LC-MS for residual HCP characterization has emerged as a powerful tool to support purification process development. However, mass spectrometry needs to overcome the enormous dynamic range to detect low ppm levels of residual HCPs in biopharmaceutical samples. We describe a simple and powerful methodology to characterize residual HCPs in (monoclonal) antibodies by combining a novel sample preparation procedure using trypsin digestion and a shotgun proteomics approach. Differing from the traditional methodology, the sample preparation approach maintains nearly intact antibody while HCPs are digested. Thus, the dynamic range for HCP detection by MS is 1 to 2 orders of magnitude less than the traditional trypsin digestion sample preparation procedure. HCP spiking experiments demonstrated that our method could detect 0.5 ppm of HCP with molecular weight >60 kDa, such as rPLBL2. Application of our method to analyze a high-purity NIST monoclonal antibody standard RM 8670 derived from a murine cell line expression system resulted in detection of 60 mouse HCPs; twice as many as previously reported with 2D-UPLC/IM/MSE method. A control monoclonal antibody used for 70 analyses over 450 days demonstrated that our method is robust.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28414239     DOI: 10.1021/acs.analchem.7b00304

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

Review 1.  Applications of Proteomics in Ovarian Cancer: Dawn of a New Era.

Authors:  Aruni Ghose; Sri Vidya Niharika Gullapalli; Naila Chohan; Anita Bolina; Michele Moschetta; Elie Rassy; Stergios Boussios
Journal:  Proteomes       Date:  2022-05-09

Review 2.  The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.

Authors:  Xuanwen Li; Fengqiang Wang; Hong Li; Douglas D Richardson; David J Roush
Journal:  Antib Ther       Date:  2022-01-15

3.  Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.

Authors:  Xuanwen Li; Yan An; Jing Liao; Li Xiao; Michael Swanson; Kirby Martinez-Fonts; Jorge Alexander Pavon; Edward C Sherer; Vibha Jawa; Fengqiang Wang; Xinliu Gao; Simon Letarte; Douglas D Richardson
Journal:  Biotechnol Prog       Date:  2021-03-12

4.  Improving the analytical toolbox to investigate copurifying host cell proteins presence: N-(4)-(β-acetylglucosaminyl)- l-asparaginase case study.

Authors:  Séverine Clavier; Delphine Fougeron; Suzana Petrovic; Hagit Elmaleh; Céline Fourneaux; Dawid Bugnazet; Francis Duffieux; Alessandro Masiero; Shibani Mitra-Kaushik; Bruno Genet; Yann Fromentin; Patrick Kreiss; Bénédicte Laborderie; Dominique Brault; Jean-Michel Menet
Journal:  Biotechnol Bioeng       Date:  2020-08-03       Impact factor: 4.395

5.  Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development.

Authors:  Rosalynn Molden; Mengqi Hu; Sook Yen E; Diana Saggese; James Reilly; John Mattila; Haibo Qiu; Gang Chen; Hanne Bak; Ning Li
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.

Authors:  Daniel M Waldera-Lupa; Yvonne Jasper; Pia Köhne; Ronja Schwichtenhövel; Heiner Falkenberg; Thomas Flad; Peter Happersberger; Bernd Reisinger; Alireza Dehghani; Roland Moussa; Thomas Waerner
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.